vitamin k Clinical Research Trials

Efficacy of a Didactic Intervention in Anticoagulated Patients (TAOPE Study)

Background: Oral anticoagulant drugs represent an essential tool in thrombo-embolic events prevention. Most used are vitamin K antagonists (VKA), which plasma level is monitored measuring

1 views
22 Jan, 2021
2 locations

SLOW-Slower Progress of caLcificatiOn With Vitamin K2

annulus and ascending Aorta.Exclusion criteria: Chronic Kidney disease, Vitamin K antagonists, statins, age < 50 y.o,prosthetic valves,Aortic Valve area (AVA) < 1cm2 ,Vmax > 4 m/s

vitamin k

stenosis

aortic valve stenosis

2 views
24 Jan, 2021
2 locations

Resolution of Thrombi in Left Atrial Appendage With Edoxaban

cases (> 90%). Anticoagulation with a vitamin-K antagonist (VKA) is recommended to prevent thromboembolic complications and to resolve thrombi. Non-VKA oral anticoagulants (NOACs) have replaced the

fibrillation

atrial flutter

noac

stroke

edoxaban

0 views
25 Jan, 2021
11 locations

Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes

and insulin) leads to decreased therapeutic efficacy of the blood-thinning vitamin-K antagonist warfarin. Due to the non-specific effect of glucose lowering drugs, the investigators hypothesize that

sulfonylurea

body mass index

metformin

plasma glucose

antidiabetic agents

0 views
29 Jan, 2021
1 location

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)

Vitamin K (AVK) or direct oral anticoagulants (DOACs)). Today there are about 1.4 million people on oral anticoagulants, 40% of whom are over 80 years of age. The peri-operative management of the AVK is

laser ablation

acute retention of urine

prostatectomy

benign prostatic hyperplasia

haemostasis

2 views
05 Feb, 2021
1 location

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Perioperative Atrial Fibrillation After Noncardiac Surgery

Pilot study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient perioperative atrial fibrillation after noncardiac surgery and additional stroke risk factors.

apixaban

fibrillation

rivaroxaban

vitamin k

stroke

36 views
26 Jan, 2021
7 locations

The Vitamin K2 and D3 Intervention Trial in Children and Adolescents With the Low-energy Fractures

a prospective, three- month, randomized, double-blind, placebo-controlled, intervention trial (RDBPC), investigating the effect of vitamin K2 (menaquinone-7) and vitamin D3 on the healing process of low-energy bone fractures in children and adolescents

0 views
17 Feb, 2021
1 location

Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

Postoperative recurrence of hepatocellular carcinoma (HCC) is a major problem after surgical resection. To date, adjuvant chemotherapy or other adjuvant modalities have not been proven effective in preventing or delaying recurrence. The aim of this prospective randomized study was to evaluate the effectiveness of Thalidomide as a postoperative adjuvant regimen …

thalidomide

TACE

6 views
08 Nov, 2020
1 location

RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding

A large proportion of women with menstruating potential with newly diagnosed VTE or atrial fibrillation, treated with apixaban will have less menstrual blood loss than patients randomized to rivaroxaban.

apixaban

anticoagulation therapy

rivaroxaban

anticoagulants

210 views
23 Jan, 2021
2 locations

Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban

The objective of this study is to compare oral rivaroxaban with injectable enoxaparin in orthopaedic trauma patients to determine if orally administered rivaroxaban once daily carries greater compliance and overall satisfaction than enoxaparin self-administered by subcutaneous injection once daily.

enoxaparin

thrombosis

venous thrombosis

deep venous thrombosis of lower extremity

thrombosis prophylaxis

5 views
23 Jan, 2021
1 location

Filter By

Found 78 clinical trials